Skrzynski Adam K, Darmstadter Brooke L, Miner Sharon P, Subedi Keshab, Kahal Deborah
ChristianaCare, William J. Holloway Community Program.
ChristianaCare, Value Institute.
Dela J Public Health. 2021 Dec 15;7(5):72-78. doi: 10.32481/djph.2021.12.016. eCollection 2021 Dec.
To better characterize the intersection of the HIV and SARS-CoV-2 pandemics, including our robust statewide panel of people living with HIV, in the State of Delaware.
We conducted a retrospective descriptive case-series that identified people living with HIV ≥ 18 years old co-infected with SARS-CoV-2 from 1 March 2020 through 9 March 2021 who attended our ambulatory HIV program, through review of testing results, electronic medical records and external clinical records.
There were 105 confirmed cases of SARS-CoV-2 infection and 4 attributable deaths from COVID-19 among adult people living with HIV from 1 March 2020 through 9 March 2021. Co-infected patients had very high rates of ART prescription and virologic suppression, with robust CD4 counts. 24/105 (22.9%) SARS-CoV-2 cases were hospitalized due to COVID-19 and had a significant burden of co-morbidities; a vast majority were AIDS-defined. Age, BMI >30 kg/m, cardiovascular disease, chronic kidney disease and cirrhosis were independently associated with hospitalization by logistic regression. Black patients appeared to have lower rates of testing and higher rates of hospitalization. Additionally, those with history of natural immunity to hepatitis B virus exhibited a low rate of hospitalization.
Our cohort data is the first to capture the experience of patients co-infected with HIV/SARS-CoV-2 in Delaware, demonstrating the risk of long-term immunosuppression and burden of comorbid disease, even in the setting of virologic suppression. Although not reaching statistical significance, we identified high rates of resolved hepatitis B virus infection amongst non-hospitalized co-infected patients and postulate there may be an underlying immunologic mechanism to this hypothesis-generating observation. Our results also highlight the role that healthcare disparities have played during these overlapping pandemics.
Pronounced healthcare disparities are known to worsen outcomes in a variety of disease states. From our descriptive data, we suggest continued efforts to address the social determinants of health, especially as they pertain to common chronic comorbid conditions and certain Black communities.
为了更好地描述艾滋病病毒(HIV)大流行与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行的交叉情况,包括特拉华州强大的全州HIV感染者群体。
我们进行了一项回顾性描述性病例系列研究,通过审查检测结果、电子病历和外部临床记录,确定了2020年3月1日至2021年3月9日期间参加我们门诊HIV项目的18岁及以上同时感染SARS-CoV-2的HIV感染者。
2020年3月1日至2021年3月9日期间,成年HIV感染者中有105例确诊SARS-CoV-2感染病例,4例因2019冠状病毒病(COVID-19)死亡。合并感染患者的抗逆转录病毒治疗(ART)处方率和病毒学抑制率非常高,CD4细胞计数良好。105例SARS-CoV-2病例中有24例(22.9%)因COVID-19住院,且合并症负担较重;绝大多数为艾滋病定义的疾病。通过逻辑回归分析,年龄、体重指数(BMI)>30 kg/m²、心血管疾病、慢性肾脏病和肝硬化与住院独立相关。黑人患者的检测率似乎较低,住院率较高。此外,对乙型肝炎病毒具有自然免疫力史的患者住院率较低。
我们的队列数据首次记录了特拉华州HIV/SARS-CoV-2合并感染患者的情况,表明即使在病毒学抑制的情况下,也存在长期免疫抑制风险和合并症负担。虽然未达到统计学显著性,但我们发现非住院合并感染患者中乙型肝炎病毒感染清除率较高,并推测这一产生假设的观察结果可能存在潜在的免疫机制。我们的结果还凸显了医疗保健差异在这些重叠大流行期间所起的作用。
众所周知,明显的医疗保健差异会使各种疾病状态的结局恶化。根据我们的描述性数据,我们建议继续努力解决健康的社会决定因素,特别是那些与常见慢性合并症和某些黑人社区相关的因素。